Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R T Oliver

Showing results (121-130 of 158) with videos related to

Pageof 16
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Immunological paradox in testicular tumours: the presence of a large number of activated T-cells despite the complete absence of MHC antigensA M Nouri, R F Hussain, R T Oliver, et al.
Urologia Internationalis|December 13, 2001
Phase 1/2 study of synchronous methotrexate, cisplatin, vincristine (MOPq10) chemotherapy and radiation for patients with locally advanced bladder cancerT I Goonewardene, H Bozcuk, R T Oliver, et al.
British Journal of Urology|December 1, 1985
Serum and tissue tumour markers in seminomasT F Ford, D N Butcher, C T Samuell, et al.
The Quarterly Journal of Medicine|December 1, 1993
Does the rapid response to cisplatin-based chemotherapy justify its use as primary treatment for intracranial germ-cell tumours?S Vijayaraghavan, C Brock, J P Monson, et al.
Transfusion|July 1, 1982
Prophylactic granulocyte transfusions: results of a randomized controlled trial in patients with acute myelogenous leukemiaJ M Ford, M H Cullen, M M Roberts, et al.
British Journal of Urology|April 1, 1990
Prediction of response to radiotherapy in invasive bladder cancerB J Jenkins, J E Martin, S I Baithun, et al.
British Journal of Urology|December 1, 1983
Evaluation of radiotherapy and/or surgicopathological staging after chemotherapy in the management of metastatic germ cell tumoursR T Oliver, J P Blandy, W F Hendry, et al.
Gynecologic Oncology|October 1, 1996
Long-term follow-up of gonadotrophin-releasing hormone analog treatment for recurrent endometrial cancerA R Jeyarajah, C J Gallagher, P R Blake, et al.
Journal of Immunogenetics|August 1, 1989
Biological significance of beta hCG, HLA and other membrane antigen expression on bladder tumours and their relationship to tumour infiltrating lymphocytes (TIL)R T Oliver, A M Nouri, D Crosby, et al.
British Journal of Urology|November 14, 1997
A single-centre observational study of surgery and late malignant events after chemotherapy for germ cell cancerR Ravi, R T Oliver, J Ong, et al.
Pageof 16

Showing results (121-130 of 158) with videos related to

Sort By:
Pageof 16
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Immunological paradox in testicular tumours: the presence of a large number of activated T-cells despite the complete absence of MHC antigensA M Nouri, R F Hussain, R T Oliver, et al.
Urologia Internationalis|December 13, 2001
Phase 1/2 study of synchronous methotrexate, cisplatin, vincristine (MOPq10) chemotherapy and radiation for patients with locally advanced bladder cancerT I Goonewardene, H Bozcuk, R T Oliver, et al.
British Journal of Urology|December 1, 1985
Serum and tissue tumour markers in seminomasT F Ford, D N Butcher, C T Samuell, et al.
The Quarterly Journal of Medicine|December 1, 1993
Does the rapid response to cisplatin-based chemotherapy justify its use as primary treatment for intracranial germ-cell tumours?S Vijayaraghavan, C Brock, J P Monson, et al.
Transfusion|July 1, 1982
Prophylactic granulocyte transfusions: results of a randomized controlled trial in patients with acute myelogenous leukemiaJ M Ford, M H Cullen, M M Roberts, et al.
British Journal of Urology|April 1, 1990
Prediction of response to radiotherapy in invasive bladder cancerB J Jenkins, J E Martin, S I Baithun, et al.
British Journal of Urology|December 1, 1983
Evaluation of radiotherapy and/or surgicopathological staging after chemotherapy in the management of metastatic germ cell tumoursR T Oliver, J P Blandy, W F Hendry, et al.
Gynecologic Oncology|October 1, 1996
Long-term follow-up of gonadotrophin-releasing hormone analog treatment for recurrent endometrial cancerA R Jeyarajah, C J Gallagher, P R Blake, et al.
Journal of Immunogenetics|August 1, 1989
Biological significance of beta hCG, HLA and other membrane antigen expression on bladder tumours and their relationship to tumour infiltrating lymphocytes (TIL)R T Oliver, A M Nouri, D Crosby, et al.
British Journal of Urology|November 14, 1997
A single-centre observational study of surgery and late malignant events after chemotherapy for germ cell cancerR Ravi, R T Oliver, J Ong, et al.
Pageof 16